TG and hypothyroidism: In conclusion, the results of this retrospective single-center analysis indicate that a history of hypothyroidism, as well as thyroid hormone replacement therapy with levothyroxine, might be associated with a beneficial outcome in patients with resectable gastroesophageal cancer.